Does early systemic sclerosis really exist?

References

1. • Denton C.P.
   • Khanna D.
   Systemic sclerosis.
   Lancet. 2017; 390: 1685-1699
   View in Article

   • Google Scholar
2. • Nihtyanova S.I.
   • Tang E.C.
   • Coghlan J.G.
   • Wells A.U.
   • Black C.M.
   • Denton C.P.
   Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study.
   QJM. 2010; 103: 109-115
   View in Article

   • Google Scholar
3. • Valentini G.
   • Cuomo G.
   • Abignano G.
   • Petrillo A.
   • Vettori S.
   • Capasso A.
   • et al.
   Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features.
   Rheumatology. 2011; 50: 317-323
   View in Article

   • Google Scholar
4. • Kallenberg C.G.
   • Wouda A.A.
   • Hoet M.H.
   • van Venrooij W.J.
   Development of connective tissue disease in patients presenting with Raynaud’s phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting.
   Ann Rheum Dis. 1988; 47: 634-641
   View in Article

   • Google Scholar
5. • Avouac J.
   • Fransen J.
   • Walker U.A.
   • Riccieri V.
   • Smith V.
   • Muller C.
   • et al.
   Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group.
   Ann Rheum Dis. 2011; 70: 476-481
   View in Article

   • Google Scholar
6. • LeRoy E.C.
   • Black C.
   • Fleischmajer R.
   • Jablonska S.
   • Krieg T.
   • Medsger Jr., T.A.
   • et al.
   Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.
   J Rheumatol. 1988; 15: 202-205
   View in Article

   • Google Scholar
7. • Trapiella-Martinez L.
   • Diaz-Lopez J.B.
   • Caminal-Montero L.
   • Tolosa-Vilella C.
   • Guillen-Del Castillo A.
   • Colunga-Arguelles D.
   • et al.
   Very early and early systemic sclerosis in the Spanish scleroderma Registry (RESCLE) cohort.
   Autoimmun Rev. 2017; 16: 796-802
   View in Article

   • Google Scholar
8. Systemic sclerosis: current pathogenetic concepts and future prospects for targeted therapy.
   Lancet. 1996; 347: 1453-1458
   View in Article

   • Google Scholar
9. • LeRoy E.C.
   • Medsger Jr., T.A.
   Criteria for the classification of early systemic sclerosis.
   J Rheumatol. 2001; 28: 1573-1576
   View in Article

   • Google Scholar
10. • Koenig M.
    • Joyal F.
    • Fritzler M.J.
    • Roussin A.
    • Abrahamowicz M.
    • Boire G.
    • et al.
    Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud’s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
    Arthritis Rheum. 2008; 58: 3902-3912
    View in Article

    • Google Scholar
11. • van den Hoogen F.
    • Khanna D.
    • Fransen J.
    • Johnson S.R.
    • Baron M.
    • Tyndall A.
    • et al.
    2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.
    Arthritis Rheum. 2013; 65: 2737-2747
    View in Article

    • Google Scholar
12. • Bellando-Randone S.
    • Matucci-Cerinic M.
    Very early systemic sclerosis and pre-systemic sclerosis: definition, recognition, clinical relevance and future directions.
    Curr Rheumatol Rep. 2017; 19: 65
    View in Article

    • Google Scholar
13. • Bruni C.
    • Guiducci S.
    • Bellando-Randone S.
    • Lepri G.
    • Braschi F.
    • Fiori G.
    • et al.
    Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis.
    Rheumatology. 2015; 54: 72-76
    View in Article

    • Google Scholar
14. • Vasile M.
    • Avouac J.
    • Sciarra I.
    • Stefanantoni K.
    • Iannace N.
    • Cravotto E.
    • et al.
    From VEDOSS to established systemic sclerosis diagnosis according to ACR/EULAR 2013 classification criteria: a French-Italian capillaroscopic survey.
    Clin Exp Rheumatol. 2018; 36: 82-87
    View in Article

    • Google Scholar
15. • Lepri G.
    • Guiducci S.
    • Bellando-Randone S.
    • Giani I.
    • Bruni C.
    • Blagojevic J.
    • et al.
    Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS/EUSTAR centre.
    Ann Rheum Dis. 2015; 74: 124-128
    View in Article

    • Google Scholar
16. • Sanchez-Cano D.
    • Ortego-Centeno N.
    • Callejas J.L.
    • Fonollosa Pla V.
    • Rios-Fernandez R.
    • Tolosa-Vilella C.
    • et al.
    Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
    Rheumatol Int. 2018; 38: 363-374
    View in Article

    • Google Scholar
17. • Khanna D.
    • Gladue H.
    • Channick R.
    • Chung L.
    • Distler O.
    • Furst D.E.
    • et al.
    Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension.
    Arthritis Rheum. 2013; 65: 3194-3201
    View in Article

    • Google Scholar
18. • Bruni C.
    • De Luca G.
    • Lazzaroni M.G.
    • Zanatta E.
    • Lepri G.
    • Airo P.
    • et al.
    Screening for pulmonary arterial hypertension in systemic sclerosis: a systematic literature review.
    Eur J Intern Med. 2020; 78: 17-25
    View in Article

    • Google Scholar
19. • Allanore Y.
    • Meune C.
    N-terminal pro brain natriuretic peptide: the new cornerstone of cardiovascular assessment in systemic sclerosis.
    Clin Exp Rheumatol. 2009; 27: 59-63
    View in Article

    • Google Scholar
20. • Ross L.
    • Prior D.
    • Proudman S.
    • Vacca A.
    • Baron M.
    • Nikpour M.
    Defining primary systemic sclerosis heart involvement: a scoping literature review.
    Semin Arthritis Rheum. 2019; 48: 874-887
    View in Article

    • Google Scholar
21. • Bosello S.
    • De Luca G.
    • Berardi G.
    • Canestrari G.
    • de Waure C.
    • Gabrielli F.A.
    • et al.
    Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: a prospective study.
    Eur J Intern Med. 2019; 60: 46-53
    View in Article

    • Google Scholar
22. • Valentini G.
    • Pope J.E.
    Undifferentiated connective tissue disease at risk for systemic sclerosis: which patients might be labeled prescleroderma?.
    Autoimmun Rev. 2020; 19102659
    View in Article

    • Google Scholar
23. • Valentini G.
    • Vettori S.
    • Cuomo G.
    • Iudici M.
    • D’Abrosca V.
    • Capocotta D.
    • et al.
    Early systemic sclerosis: short-term disease evolution and factors predicting the development of new manifestations of organ involvement.
    Arthritis Res Ther. 2012; 14: R188
    View in Article

    • Google Scholar
24. • Simeon-Aznar C.P.
    • Fonollosa-Pla V.
    • Tolosa-Vilella C.
    • Espinosa-Garriga G.
    • Ramos-Casals M.
    • Campillo-Grau M.
    • et al.
    Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Semin Arthritis Rheum. 2012; 41: 789-800
    View in Article

    • Google Scholar